Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 75Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Cozaar

02 12Cozaar/Hyzaar

PharmaCompass

01

Brand Name : Cozaar/Hyzaar

Losartan

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 386

2019 Revenue in Millions : 442

Growth (%) : -13

blank

02

Brand Name : Cozaar/Hyzaar

Losartan

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 357

2020 Revenue in Millions : 386

Growth (%) : -8

blank

03

Brand Name : Cozaar/Hyzaar

Losartan

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 357

2020 Revenue in Millions : 386

Growth (%) : -8

blank

04

Brand Name : Cozaar/Hyzaar

Losartan

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 323

2021 Revenue in Millions : 357

Growth (%) : -10

blank

05

Brand Name : Cozaar/Hyzaar

Losartan Potassium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan Potassium

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 323

2021 Revenue in Millions : 357

Growth (%) : -10

blank

06

Brand Name : Cozaar/Hyzaar

Potassium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Potassium

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 281

2022 Revenue in Millions : 323

Growth (%) : -13

blank

07

Brand Name : Cozaar/Hyzaar

Losartan

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 281

2022 Revenue in Millions : 323

Growth (%) : -13

blank

08

Brand Name : Cozaar/Hyzaar

Losartan and Hydrochlorothiazide

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan and Hydrochlorothiazide

Main Therapeutic Indication : Antihypertensives

Currency : USD

2015 Revenue in Millions : 806

2014 Revenue in Millions : 667

Growth (%) : -17%

blank

09

Brand Name : Cozaar

Losartan and Hydrochlorothiazide

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar

arrow
BioFlorida Conference
Not Confirmed

Losartan and Hydrochlorothiazide

Main Therapeutic Indication : Antihypertensives

Currency : USD

2014 Revenue in Millions : -19.90%

2013 Revenue in Millions :

Growth (%) :

blank

10

Brand Name : Cozaar/Hyzaar

Losartan And Hydrochlorothiazide

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Cozaar/Hyzaar

arrow
BioFlorida Conference
Not Confirmed

Losartan And Hydrochlorothiazide

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 511

2015 Revenue in Millions : 667

Growth (%) : -23

blank